Patenting antibodies in Europe.
作者信息
Holliday Louise
机构信息
D. Young & Co., Briton House, Southampton SO14 3EB, UK.
出版信息
MAbs. 2009 Jul-Aug;1(4):385-6. doi: 10.4161/mabs.1.4.8802.
Abstract
摘要
相似文献
1
Patenting antibodies in Europe.
MAbs. 2009 Jul-Aug;1(4):385-6. doi: 10.4161/mabs.1.4.8802.
2
Europe tries to untangle laws on patenting life.
Science. 1989 Feb 24;243(4894 Pt 1):1002.
3
Biotechnology patenting policy in the European Union--as exemplified by the development in Germany.
Adv Biochem Eng Biotechnol. 2007;107:13-39. doi: 10.1007/10_2007_049.
4
Patenting animals in Europe.
Biotechnology (N Y). 1991 Jul;9(7):619-22. doi: 10.1038/nbt0791-619.
5
Patents: patenting of stem cell related inventions in Europe.
Biotechnol J. 2006 Apr;1(4):384-7. doi: 10.1002/biot.200600021.
6
Biotechnology patents and ethical aspects.
Cancer Detect Prev. 1993;17(2):317-21.
7
Ethical aspects of patenting human genotypes according to EC Biotechnology Directive.
IIC Int Rev Ind Prop Copyr Law. 2000 Jun;31(4):373-80.
8
Patenting of human embryonic stem cells in Europe.
Biotechnol J. 2009 Apr;4(4):462-4. doi: 10.1002/biot.200900022.
9
Patenting in biotechnology: a review of the 20th symposium of ECB8.
J Biotechnol. 1999 Jan 8;67(1):1-11. doi: 10.1016/s0168-1656(98)00137-0.
10
Patenting transgenics in the European Union.
Nat Biotechnol. 1998 Mar;16(3):299-301. doi: 10.1038/nbt0398-299.
引用本文的文献
1
The N14 anti-afamin antibody Fab: a rare V1 CDR glycosylation, crystallographic re-sequencing, molecular plasticity and conservative versus enthusiastic modelling.
Acta Crystallogr D Struct Biol. 2016 Dec 1;72(Pt 12):1267-1280. doi: 10.1107/S205979831601723X. Epub 2016 Nov 29.
2
5th European Antibody Congress 2009: November 30–December 2, 2009, Geneva, Switzerland.
MAbs. 2010 Mar-Apr;2(2):108-28. doi: 10.4161/mabs.2.2.11302.
3
European Medicines Agency workshop on biosimilar monoclonal antibodies: July 2, 2009, London, UK.
MAbs. 2009 Sep-Oct;1(5):394-416. doi: 10.4161/mabs.1.5.9630. Epub 2009 Sep 25.
Zotero 插件